{
    "organizations": [],
    "uuid": "13250f3462b5ed4f1283cc3d2ee8b5e0910876ae",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-senzime-signs-additional-distribut/brief-senzime-signs-additional-distribution-agreements-for-tetragraph-idUSFWN1QP03Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Senzime Signs Additional Distribution Agreements For TetraGraph",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - SENZIME AB (PUBL):\n* SENZIME SIGNS ADDITIONAL DISTRIBUTION AGREEMENTS FOR THE TETRAGRAPH\n* ‍HAS ENTERED EXCLUSIVE DISTRIBUTION AGREEMENTS FOR COMMERCIALIZATION OF TETRAGRAPH WITH EIKOS CARE MEDICAL​\n* ENTERS AGREEMENT WITH GERANSWERS MEDICAL SOLUTIONS WHO WILL BE EXCLUSIVE DISTRIBUTOR IN PORTUGAL​\n* EIKOS CARE MEDICAL WILL BE EXCLUSIVE DISTRIBUTOR IN SPAIN​\n* ‍AGREEMENT IS BASED ON A COMPENSATION SCHEME OF “PER-UNIT SOLD” BASIS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-07T15:34:00.000+02:00",
    "crawled": "2018-03-08T17:03:23.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "senzime",
        "ab",
        "publ",
        "senzime",
        "sign",
        "additional",
        "distribution",
        "agreement",
        "tetragraph",
        "entered",
        "exclusive",
        "distribution",
        "agreement",
        "commercialization",
        "tetragraph",
        "eikos",
        "care",
        "enters",
        "agreement",
        "geranswers",
        "medical",
        "solution",
        "exclusive",
        "distributor",
        "eikos",
        "care",
        "medical",
        "exclusive",
        "distributor",
        "based",
        "compensation",
        "scheme",
        "sold",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}